Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-053165)

Filing Details

Accession Number:: 0001209191-17-053165
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-18 16:40:55
Reporting Period:: 2017-09-14

Accepted Time:: 2017-09-18 16:40:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367920	Concert Pharmaceuticals Inc.	CNCE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1709271	Ryan Lynch	C/O Concert Pharmaceuticals, Inc. 99 Hayden Avenue, Suite 500 Lexington MA 02421	Pfo, Pao	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-14	3,500	$9.46	9,500	No	4	M	Direct
Common Stock	Disposition	2017-09-14	3,500	$14.51	6,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2017-09-14	3,500	$0.00	3,500	$9.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,200		2024-06-11	No	4	M	Direct

Footnotes

Twenty five percent (25%) of the shares subject to this option vested on June 12, 2015, and the option vested and will continue to vest in equal quarterly installments thereafter, until June 12, 2018, at which time this option will be fully vested.